Cyted - About the company
Cyted is a series B company based in Cambridge (United Kingdom), founded in 2018 by Rebecca Fitzgerald, Maria Odonovan and Marcel Gehrung. It operates as a Leader in non-endoscopic diagnostics for digestive health, enabling early disease detection and access to care for all. Cyted has raised $50.4M in funding from investors like British Business Bank, Advent Life Sciences and EQT. The company has 95 active competitors, including 26 funded and 7 that have exited. Its top competitors include companies like Lunit, Apollo Endo and NEOGAP.
Company Details
Cyted Health is a gastrointestinal health company pioneering non-endoscopic diagnostics to detect diseases early and provide access to care for everyone. Their technologies aim to revolutionize diagnostics and improve patient care.
- Website
- www.cytedhealth.com/
- Social
- Email ID
- *****@cytedhealth.com
- Registered Address
- 2 FALCON ROAD,HINCHINGBROOKE BUSINESS PARK,HUNTINGDON,CAMBRIDGESHIRE,UNITED KINGDOM,PE29 6FG
Key Metrics
Founded Year
2018
Location
Cambridge, United Kingdom
Stage
Series B
Total Funding
$50.4M in 6 rounds
Latest Funding Round
Investors
Ranked
3rd among 95 active competitors
Employee Count
73 as on Jul 31, 2026
Legal entities associated with Cyted
Cyted is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Cyted Ltd CIN: 11478299 , United Kingdom, Active | Jul 22, 2018 | - | 8 (As on Jan 31, 2020) | |
CYTED UK LTD CIN: 10360685 , United Kingdom, Active | Sep 05, 2016 | - | 5 (As on Dec 31, 2020) |
Sign up to download Cyted's company profile
Cyted's funding and investors
Cyted has raised a total funding of $50.4M over 6 rounds. Its first funding round was on Jan 31, 2020. Its latest funding round was a Series B round on Sep 01, 2025 for $*****. 5 investors participated in its latest round. Cyted has 5 institutional investors.
Here is the list of recent funding rounds of Cyted:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 01, 2025 | 2220978 | Series B | 5564953 | 7958107 | 2422596 | 3796024 |
Dec 11, 2020 | 1584134 | Series A | 5839916 | 5505188 | 1702672 | 7222885 |
Oct 07, 2020 | 9533444 | Series A | 3218899 | 5919585 | 8787430 | 9931777 |
Access funding benchmarks and valuations. Sign up today!View details of Cyted's funding rounds and investors
Cyted's founders and board of directors
Founder? Claim ProfileThe founders of Cyted are Rebecca Fitzgerald, Maria Odonovan and Marcel Gehrung. Marcel Gehrung is the CEO of Cyted.
Here are the details of Cyted's key team members:
- Rebecca Fitzgerald: Co-Founder & CSO of Cyted and founder of 1 other company. Contact Info: 1 email address
- Maria Odonovan: Co-Founder & CMO of Cyted and founder of 1 other company. Contact Info: 1 email address
- Marcel Gehrung: Co-Founder & CEO of Cyted and founder of 1 other company. Contact Info: 2 email addresses
View details of Cyted's Founder profiles and Board Members
Cyted's employee count trend
Cyted has 73 employees as of Jul 26. Here is Cyted's employee count trend over the years:
Uncover Cyted's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cyted's Competitors and alternates
Top competitors of Cyted include Lunit, Apollo Endo and NEOGAP. Here is the list of Top 10 competitors of Cyted, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Lunit 2013, Seoul (South Korea), Public | Developer of medical software for cancer screening and oncology diagnostics | $135M | 71/100 | |
2nd | Apollo Endo 2005, Austin (United States), Acquired | Developer of therapeutic devices for obesity and other GI disorders | $80.4M | 58/100 | |
3rd |  Cyted 2018, Cambridge (United Kingdom), Series B | Leader in non-endoscopic diagnostics for digestive health, enabling early disease detection and access to care for all | $50.4M | 57/100 | |
4th | Developer of radiopharmaceuticals for the treatment of cancer | $10.2M | 55/100 | ||
5th |  Leal 2017, New York City (United States), Acquired | Provider of an AI-powered platform matching cancer patients with treatment options. | $27.7M | 55/100 | |
6th |  Lucid Diagnostics 2018, New York City (United States), Public | Developer of diagnostic kit for oesophagal cancer | - | - | 53/100 |
7th |  Azra 2022, Franklin (United States), Series A | AI and machine learning to automate oncology workflows | $7.95M | 52/100 | |
8th | PAVmed 2014, New York City (United States), Public | Developer of medical devices and biomarkers to detect various diseases | $845K | 50/100 | |
9th | Cernostics 2008, Pittsburgh (United States), Acquired | Diagnostic and prognostic tests for Esophageal Cancer | $14.2M | 49/100 | |
10th | Provider of AI-powered oncology dosimetry software and services | $18.9M | 49/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cyted's competitors? Click here to see the top ones
Cyted's Investments and acquisitions
Cyted has made no investments or acquisitions yet.
Reports related to Cyted
Here is the latest report on Cyted's sector:
News related to Cyted
Media has covered Cyted for a total of 2 events in the last 1 year.
•
UK diagnostics firm Cyted Health secures $44m series BTech in Asia•Sep 02, 2025•Cyted, Morningside, EQT, British Business Bank and 3 others
•
•
•
Cyted Launch Precision Medicine Initiative for Non-Endoscopic Testing of Eosinophilic EsophagitisEuropean Pharmaceutical Manufacturer•Dec 13, 2023•Cyted, Ukri
•
Cambridge-based Cyted bags €15.4M to revolutionise early cancer diagnosticsSilicon Canals•May 19, 2023•Cyted, BGF, Morningside
•
Cyted wins £3.4m to increase reach of NHS diagnostic testingBusiness Weekly newspaper•Apr 28, 2023•Cyted
•
Fast growing Cyted takes space at Hinchingbrooke Business ParkBusiness Weekly newspaper•Aug 17, 2021•Cyted, Eddisons
•
Cyted selected as one of 12 innovators to scale across England’s NHS with support from the NHS Innovation AcceleratorCambridge Network•Mar 08, 2021•Cyted
•
Cyted scales through strategic acquisitionBusiness Weekly newspaper•Oct 19, 2020•Cyted, Pathognomics, Cyted
•
Cyted appoints Martin Frost as Commercial and Strategic AdvisorCambridge Network•Sep 30, 2020•Cyted, CMR Surgical
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Cyted
Explore our recently published companies
- Marc Unger - Founder - United States based, 2026 founded, Stealth company
- Luis Casillas - Founder - Zapopan based, 2025 founded, Stealth company
- Kevin Navi - Founder - United States based, 2026 founded, Stealth company
- Reagan Meek - Founder - New York based, 2025 founded, Stealth company
- Tim Rich - Principal Product Manager - United States based, 2025 founded, Stealth company
- Edward Chong Rong Shiu - Founding Engineer - Malaysia based, 2025 founded, Stealth company
